Figure 8 demonstrates a proposed model for both RTK- and NRTK-mediated signaling pathways, PI3K/AKT, PI3K/AKT/mTOR, and RAS/RAF/MEK/ERK, in different tumor types including melanoma. This evidence concerns the gene MAP2K7 and melanoma.